VANCOUVER, British Columbia - November 9, 2017 (Investorideas.com Newswire) Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the "Company" or "Isodiol"), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce the Company's entrance into the vaping industry by signing a Letter of Intent ("LOI") to acquire Bradley's Bioscience Inc.

More From BioPortfolio on "Isodiol International (CSE:ISOL) (OTC:ISOLF) Signs Letter of Intent to Acquire Bradley's Bioscience Inc., Expands Into #Vaping and THC Additive Industries"

Relevant Topic

BioscienceBioscience - any of the sciences that deal with living organisms. The study of the nature, behavior, and uses of living organisms as applied to biology.
Any of the branches of natural science dealing with living things, such as their structure, b...